Who
John L. Flavin
Director
Company insider
Files Form 4 as: Director, Pyxis Oncology; President /Chief Financial Off, Advanced Life Sciences Holdings.
In numbers
- Trades disclosed
- 17
- Buys
- 1
- Sells
- 0
- Bought
- $1,092
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 10 Mar 2006
- Last trade
- 24 Mar 2026
- Last filed
- 25 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Mar 2026filed 25 Mar 2026 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,867 at $0.00 | filing |
| 24 Mar 2026filed 25 Mar 2026 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,867 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | $36K36,979 at $0.98 | filing |
| 26 Mar 2024filed 28 Mar 2024 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —35,219 at $0.00 | filing |
| 24 Mar 2023filed 28 Mar 2023 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —139,355 at $0.00 | filing |
| 31 Mar 2022filed 4 Apr 2022 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code A | —66,831 at $0.00 | filing |
| 13 Oct 2021filed 15 Oct 2021 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code C | —15,190 at $0.00 | filing |
| 13 Oct 2021filed 15 Oct 2021 | PYXS Pyxis OncologyBiotechnology | SEC FORM 4 Code C | —2,388 | filing |
| 7 Oct 2021filed 12 Oct 2021 | PYXS Pyxis Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,191 at $0.00 | filing |
| 16 Aug 2010filed 18 Aug 2010 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | —397,402 at $0.00 | filing |
| 25 Nov 2009filed 30 Nov 2009 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 15 May 2009filed 18 May 2009 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | —82,000 at $0.00 | filing |
| 11 Nov 2008filed 14 Nov 2008 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | —52,371 at $0.00 | filing |
| 27 Feb 2008filed 27 Feb 2008 | Advanced Life Sciences Holdings | SEC FORM 4 Bought | $1,0921,200 at $0.91 | filing |
| 22 Feb 2008filed 26 Feb 2008 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | —78,700 at $0.00 | filing |
| 4 Jan 2007filed 5 Jan 2007 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | —78,700 at $0.00 | filing |
| 10 Mar 2006filed 13 Mar 2006 | Advanced Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | $128K40,000 at $3.20 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.